Advertisement
News
Subscribe to MDT Magazine News

For cutting CT dose, start with the scout scan

December 2, 2010 7:35 am | by Diagnostic Imaging | Comments

CT scout or scanogram images make up only about 4% of the typical chest/abdominal scan radiation dose, but are an easy target for dose reductions, according to a study presented Wednesday. Further, as technology changes and protocol updates reduce overall dose rates, scout images will...

TOPICS:

NewCardio's Chief Technical Officer, Dr. Dorin Panescu, Named 2011 IEEE Fellow

December 2, 2010 7:35 am | by Bio-Medicine.Org | Comments

SANTA CLARA, Calif., Dec. 2, 2010 /- NewCardio, Inc., (OTC Bulletin Board: NWCI ) a cardiovascular diagnostic solutions developer, announced today that Dr. Dorin Panescu, Chief Technical Officer and Vice President Research and Development, has been named an IEEE Fellow, effective January...

TOPICS:

Sagent Pharmaceuticals Announces FDA Approval of Midazolam Injection, USP

December 2, 2010 7:34 am | by Bio-Medicine.Org | Comments

SCHAUMBURG, Ill., Dec. 2, 2010 /- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced U.S. FDA's approval of four presentations of midazolam injection, USP, a general anesthetic.  Sagent expects to launch midazolam, which will be offered...

TOPICS:
Advertisement

Sequenom prices stock offering worth $84 million

December 2, 2010 6:45 am | by The Associated Press | Comments

Biotechnology company Sequenom Inc. said Thursday it is publicly offering $84 million in common stock and will use proceeds for general corporate purposes, including research and development.The company is offering 14 million shares at $6 apiece, an 11.9 percent discount to its closing price of...

Remarks: MassMEDIC FDA Update Conference, December 1, 2010

December 2, 2010 6:36 am | by U.S. Food & Drug Administration | Comments

In August 2010, CDRH released for public comment the preliminary reports from the 510(k) Working Group and the Task Force on the Utilization of Science in Regulatory Decision Making. These committees were established in September 2009 to address ...

Sage Science raises $2M financing

December 2, 2010 5:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Sage Science Inc., a developer of laboratory and research-related technologies, has taken in $2.02 million in an equity offering, with an expected total offering of $2.12 million, according to a regulatory filing.

Merck acquires diabetes drug firm SmartCells

December 2, 2010 5:36 am | by Mass High Tech: The Journal of New England Technology | Comments

SmartCells Inc., a Beverly diabetes drug developer, is to be acquired by Merck & Co. Inc. for a total of about $500 million, according to a news release today. SmartCells develops a once-daily insulin treatment called SmartInsulin, based on a patent filed in 2003 covering technology...

DARPA Awards $4.3M to Develop Biological, Chemical Threat Detector

December 2, 2010 5:35 am | by Georgia Tech Institute of Technology | Comments

DARPA has awarded Georgia Tech $4.3 million to develop a new class of sensors able to detect multiple biological and chemical threats simultaneously with unprecedented performance.

Advertisement

Nordion agrees to sell Belgian subsidiary to Best Medical for undisclosed amount

December 2, 2010 4:45 am | by The Associated Press | Comments

Medical isotope supplier Nordion Inc. (TSX:NDN) agrees to sell Belgian subsidiary to Best Medical International Inc. for undisclosed amount.

Nordion has tentative deal to divest European division to Best Medical

December 2, 2010 3:45 am | by The Associated Press | Comments

Canadian nuclear medicine specialist Nordion Inc. (TSX:NDN) say it has a preliminary agreement to sell a European division to Best Medical International Inc. Nordion, formerly part of MDS Inc. before it was split up, said it will sell three of the division's lines of business and keep a fourth...

Clinical trials at The Christie: Fact sheet

December 2, 2010 3:34 am | by RealWire | Comments

Clinical trial treatments aim to discover if a drug is safe, has side effects, and works better than established treatments. They offer important opportunities for patients to access the most innovative treatments for cancer, giving them the best possible chance of survival or extended...

TOPICS:

Expert panel addresses safety in medical imaging

December 1, 2010 9:32 pm | by EurekAlert | Comments

(Radiological Society of North America) An expert panel will convene at the annual meeting of the Radiological Society of North America to discuss medical imaging appropriateness, ionizing radiation from imaging procedures and efforts under way to curb overutilization, decrease radiation...

TOPICS:

Color-Changing Badge Detects Blast Exposure

December 1, 2010 7:36 pm | by Massachusetts Institute of Technology | Comments

The nanostructure material could predict which soldiers might suffer from traumatic brain injury.

TOPICS:

Sequenom to launch public stock offering

December 1, 2010 3:45 pm | by The Associated Press | Comments

Biotech company Sequenom Inc. said Wednesday it intends to mount an underwritten public offering of its common stock.The company didn't specify the size of the offering.Jefferies & Company Inc. is the sole book-running manager for the offering.Shares fell 55 cents, or 8.1 percent, to $6.26 in...

Cigna sells part of Intracorp unit to Genex

December 1, 2010 2:46 pm | by The Associated Press | Comments

Genex Holdings Inc. said Wednesday it bought the workers' compensation and disability case management business of Intracorp, a unit of health insurer Cigna Corp., in a stock dealCigna is keeping the rest of Philadelphia-based Intracorp, which also provides health management and wellness...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading